ConductScience.org, home

Paper41399609

Using the Difference Between Estimated Glomerular Filtration Rate by Cystatin C and Creatinine to Improve Mortality Risk Prediction in Elderly Patients With CKD in the HUNT Study.

Potok OA and 4 others. Kidney Med, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Using the Difference Between Estimated Glomerular Filtration Rate by Cystatin C and Creatinine to Improve Mortality Risk Prediction in Elderly Patients With CKD in the HUNT Study. Papers, record 41399609. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41399609

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Using the Difference Between Estimated Glomerular Filtration Rate by Cystatin C and Creatinine to Improve Mortality Risk Prediction in Elderly Patients With CKD in the HUNT Study.
PubMed
Journal
Kidney Med
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-03-25
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Potok OAO Alison
2Katz RRonit
3Bansal NNisha
4Langlo KAKnut A
5Hallan SIStein I

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
K26 DK138333NIDDK NIH HHSUnited StatesK26DK138333PubMed

Source NIH RePORTER

Download CSV of grants

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132682698The Difference Between Cystatin C- and Creatinine-Based Estimated GFR and Incident Frailty: An Analysis of the Cardiovascular Health Study (CHS).Am J Kidney Dis2020https://conductscience.org/library/papers/32682698PubMed
238476830The Association of Intraindividual Difference Between Cystatin- and Creatinine-Based Estimated GFR and Contrast-Associated Acute Kidney Injury.Clin Interv Aging2024https://conductscience.org/library/papers/38476830PubMed
332682697The Difference Between Cystatin C- and Creatinine-Based Estimated GFR and Associations With Frailty and Adverse Outcomes: A Cohort Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).Am J Kidney Dis2020https://conductscience.org/library/papers/32682697PubMed
425710804Development and validation of a model to predict 5-year risk of death without ESRD among older adults with CKD.Clin J Am Soc Nephrol2015https://conductscience.org/library/papers/25710804PubMed
534554658New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race.N Engl J Med2021https://conductscience.org/library/papers/34554658PubMed
631301887
Implementing the European Renal Best Practice Guidelines suggests that prediction equations work well to differentiate risk of end-stage renal disease vs. death in older patients with low estimated glomerular filtration rate.
Kidney Int2019https://conductscience.org/library/papers/31301887PubMed
733015610Patient-Related Barriers to Timely Dialysis Access Preparation: A Qualitative Study of the Perspectives of Patients, Family Members, and Health Care Providers.Kidney Med2020https://conductscience.org/library/papers/33015610PubMed
838778286Frailty, but not cognitive impairment, improves mortality risk prediction among those with chronic kidney disease-a nationally representative study.BMC Nephrol2024https://conductscience.org/library/papers/38778286PubMed
926066476Cystatin C as a biomarker for estimating glomerular filtration rate.Curr Opin Nephrol Hypertens2015https://conductscience.org/library/papers/26066476PubMed
1027344204Long-term trends in the prevalence of chronic kidney disease and the influence of cardiovascular risk factors in Norway.Kidney Int2016https://conductscience.org/library/papers/27344204PubMed
1135386603Cystatin C- and Creatinine-Based Glomerular Filtration Rate Estimation Differences and Muscle Quantity and Functional Status in Older Adults: The Health, Aging, and Body Composition Study.Kidney Med2022https://conductscience.org/library/papers/35386603PubMed
1237742621The Good, the Bad, and the Serum Creatinine: Exploring the Effect of Muscle Mass and Nutrition.Blood Purif2023https://conductscience.org/library/papers/37742621PubMed
1321204120Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers.Stat Med2011https://conductscience.org/library/papers/21204120PubMed
1439115956Physical Function and Mortality in Older Adults with Chronic Kidney Disease.Clin J Am Soc Nephrol2024https://conductscience.org/library/papers/39115956PubMed
1538490803KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.Kidney Int2024https://conductscience.org/library/papers/38490803PubMed
1624071661
A European Renal Best Practice (ERBP) position statement on the Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline for the management of blood pressure in non-dialysis-dependent chronic kidney disease: an endorsement with some caveats for real-life application.
Nephrol Dial Transplant2014https://conductscience.org/library/papers/24071661PubMed
1739232264Effectiveness of sarcopenia screening markers in predicting out-of-hospital death in the oldest (≥80 years) older.Geriatr Nurs2024https://conductscience.org/library/papers/39232264PubMed
1830561031Sarcopenia Index Is a Simple Objective Screening Tool for Malnutrition in the Critically Ill.JPEN J Parenter Enteral Nutr2019https://conductscience.org/library/papers/30561031PubMed
1934413438Serum indices based on creatinine and cystatin C predict mortality in patients with non-dialysis chronic kidney disease.Sci Rep2021https://conductscience.org/library/papers/34413438PubMed
2021482743A predictive model for progression of chronic kidney disease to kidney failure.JAMA2011https://conductscience.org/library/papers/21482743PubMed

See all 28 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
41975774Unravelling Sarcopenia in Chronic Kidney Disease: From Pathogenesis to Diagnosis and Therapeutics.Diagnostics (Basel)2026https://conductscience.org/library/papers/41975774

Source PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CST31471PubTator's text mininghttps://conductscience.org/library/genes/1471

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41399609

GET https://conductscience.org/api/papers/v1/41399609/references?page=2